Straumann GM Helix Implant Recall: What Practices Should Do

The FDA has classified a Class 2 recall for the Straumann GM Helix Implant, filed as Recall Number Z-2929-2026. Straumann found that some cartons may not match the implant sealed inside. This article covers why the recall happened, which lot is affected, and the exact steps a practice should take before placing another GM Helix Implant.

TL;DR

• The FDA classified this as a Class 2 recall, not the most severe category.

• Straumann flagged a possible mismatch between the carton label and the implant inside.

• Practices should check inventory against Lot MVXJ9 and quarantine any matching stock.

• Already-placed implants do not need removal or extra follow-up solely because of this recall.

Recall At A Glance

The table below summarizes the recall as filed with the FDA, current as of publication.

Why Was The GM Helix Implant Recalled?

Straumann identified a possible mismatch between the implant packed inside a carton and the information printed on the outside of that carton. A clinician relying on the carton label alone, rather than confirming the implant itself, could end up placing the wrong implant.

The firm's stated concern is clinical rather than cosmetic. An incorrect implant, if installed, could cause bone compression or added difficulty during placement in cases where the site has sufficient bone volume, since the wrong implant may not match what the case was planned around. Straumann has not yet confirmed a root cause, and the FDA record lists the cause as under investigation by the firm.

This kind of label mismatch matters most at the exact step most implant cases already build in – confirming the implant against the plan before opening the packaging. A documented dental implant treatment planning process that records the system, diameter, and length by name gives a second checkpoint beyond the carton label alone, one that fits naturally into the broader practice of restorative dentistry case documentation.

Which GM Helix Implant Units Are Affected?

Only one lot is involved, which narrows the check considerably for most practices.

• Lot MVXJ9

• UDI-DI 7899878024552

• Article No. 109.984, GM Helix Implant, Endosseous Dental Implant

Cross-check any GM Helix Implant stock against the lot and UDI-DI above rather than the article number alone, since the article number applies to the product line generally and will not by itself confirm whether a specific box falls inside the recalled lot. Straumann also markets Neodent, a separate implant line under the same parent company, which is not part of this recall.

What Should Dental Practices Do Now?

Straumann began notifying customers on July 13, 2026, through mail, phone, and email, with letters sent by overnight UPS. Practices that have not received a letter but stock the GM Helix Implant should still check their inventory directly.

1. Check inventory: Search current stock for Lot MVXJ9 and UDI-DI 7899878024552, not just the general GM Helix Implant product line

2. Stop use immediately: Do not place or distribute any implant matching the affected lot

3. Quarantine the product: Physically separate any matching stock from usable inventory to prevent accidental use

4. Contact Straumann for return: Reach the firm through Todd Shevlin at 978-747-2560 to arrange return and replacement

5. Document the check: Keep a record of the inventory review as part of the practice's compliance file, useful if the recall status changes later

Practices tracking implant systems, lot numbers, and case-specific choices inside a written dental treatment plan can search that record directly rather than relying on memory or a paper invoice to confirm which lot went into which case. A dental lab technician handling case fabrication should also flag any GM Helix components already sitting in the lab's own inventory.

What If The Implant Has Already Been Placed In A Patient?

Straumann states that implant removal is not required, and no additional patient follow-up is required solely because of this recall.

That guidance applies to the packaging and labeling issue itself, not to a patient's individual clinical presentation. A patient reporting pain, mobility, or signs of complication still warrants the normal clinical workup a dentist would run for any implant, independent of this recall.

A quick review of the case record against the lot and UDI-DI above confirms whether a specific patient's implant falls inside the recalled batch, useful information to have on hand even though no action is required by default. If a replacement ever becomes necessary, how much dental implants cost covers what a patient should expect to budget for a redo case.

How Serious Is A Class 2 Recall?

The FDA sorts device recalls into three classes based on the health risk involved, and this recall sits in the middle tier.

• Class 1: Reasonable chance the product will cause serious health problems or death

• Class 2: The product may cause temporary or reversible health effects, or the risk of serious harm is remote

• Class 3: The product is unlikely to cause any adverse health effect

According to FDA guidance on medical device recalls, a Class 2 classification reflects a real but limited risk rather than an emergency-level concern. That matches the scope of this recall – one lot, 417 units, tied to a labeling issue rather than a confirmed material defect.

Where Was The Product Distributed?

Straumann shipped the affected lot nationwide rather than to a single region.

The recall covers 417 units distributed across 35 states, including California, Texas, New York, Florida, and Massachusetts. The full state list is available in the FDA recall record. The unit count is small relative to a typical nationwide implant recall, which keeps the scope narrow even though the geographic spread is wide.

Bottom Line

Straumann's GM Helix Implant recall covers one lot, MVXJ9, out of 417 units distributed nationwide, following a possible mismatch between the carton label and the implant sealed inside. The FDA classified it as a Class 2 recall, meaning the risk is real but limited rather than severe. Practices should check inventory against Lot MVXJ9 and UDI-DI 7899878024552, quarantine any matching stock, and contact Straumann for a replacement. Already-placed implants do not need removal or extra follow-up solely because of this recall, though normal clinical judgment still applies if a patient reports a problem. Confirm the latest status on the FDA recall record before acting, since this recall was open as of publication.